- ASSISTANT CLINICAL PROFESSOR | Dermatology
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Mount Sinai St. Luke's and Mount Sinai West
Dr. Lazic obtained her medical degree from Yale, where she stayed on to complete a medical internship. During her residency at Boston University’ s Roger Williams Medical Center, she served as Chief Resident, and received multiple awards for patient care and academic excellence. Dr. Lazic also studied dermatology at the University of Rome in Italy, as well as HIV Primary Care in Santiago, Chile. She is fluent in Spanish and Serbian, and conversational in Italian.
In 2012, she accepted an academic position at Mount Sinai's St. Luke’s and Roosevelt Hospitals Department of Dermatology, where she teaches dermatology residents, and sees patients in a private office setting in Manhattan.
Dr. Lazic’s dermatologic interests include medical and surgical treatment of skin disorders, and a wide variety of cosmetic procedures (Botox, fillers, microneedling, chemical peels). She particularly enjoys and specializes in diagnosing and treating allergic contact dermatitis and provides skin patch testing services.
American Board of Dermatology
- Acne Vulgaris
- Actinic Keratosis
- Age Spots
- Aging Skin
- Allergic Contact Dermatitis
- Alopecia Areata
- Atopic Dermatitis
- Basal Cell Carcinoma
- Botox Cosmetic
- Botulinum Injections-Cosmetic
- Botulinum Toxin for Hyperhidrosis
- Botulinum Toxin for Wrinkles
- Broken Blood Vessels
- Cheek filler
- Chemical Peels
- Clear & Brilliant
- Contact Dermatitis
- Cosmetic Consultation
- Cosmetic Surgery
- Dysplastic Nevi
- Facial Rejuvenation
- Facial Replenishment
- Frown Lines
- Juvederm Ultra
- Juvederm Ultra Plus
- Lip Filler
- Lip Lines
- Marionette Lines
- Neck and chest Rejuvenation
- Nevi (Moles)
- Occupational/Contact Dermatits
- Plantar Warts
- Punch Biopsy
- Skin Biopsy
- Skin Cancer
- Skin Care
- Skin Check
- Skin Rashes
- Skin Rejuvenation
- Spider Veins
- Squamous Cell Carcinoma
- Sun Damage
- Total Body Skin Exam
MD, Yale School of Medicine
Internship, Internal Medicine
Yale University School of Medicine
Roger Williams General Hospital
English, SpanishDownload the CV
Departmental Honors, GPA 3.88, Summa Cum Laude; Outstanding Senior Award; Outstanding Research Proposal “In Vivo Study of The Best Use of Herceptin in Treatment of Breast Cancer”; Honorary Societies: Alpha Lambda Delta, Phi Eta Sigma, Golden Key, Dean’s List (multiple editions); Tom Brokaw Award for Life Achievement
Excellence in Scholarly Activities (2010-2011), Excellence in Patient Care (2009-2010; 2010-2011), Chairman’s Award (2012), Hendrick Bogaard Dermatopathology Award (2012)
Outstanding Teaching Award (2014), Mentor of Year Award (2015), Outstanding Teaching Award (2016)
Mount Sinai Department of Dermatology
New York Times Magazine Superdoctors "Rising Star" Award 2014, 2015, 2016
Lazic T, Horii KA, Richard G, Wasserman DI, Antaya RJ. A report of GJB2 (N14K) Connexin 26 mutation in two patients--a new subtype of KID syndrome?. Pediatric dermatology; 25(5).
Lazic T, Falanga V. Bioengineered skin constructs and their use in wound healing. Plastic and reconstructive surgery 2011 Jan; 127 Suppl 1.
Cantisani C, Lazic T, Richetta AG, Clerico R, Mattozzi C, Calvieri S. Imiquimod 5% cream use in dermatology, side effects and recent patents. Recent patents on inflammation & allergy drug discovery 2012 Jan; 6(1).
Lazic T, Strugar J. Nail in the midbrain. Neurology 2009 Apr; 72(17).
Orme CM, Zhou LH, Lazic T. Clinically amyopathic dermatomyositis in a patient with an extramedullary plasmacytoma of the tongue. The Journal of dermatology 2012 Jul; 39(7).
Lazic T, Li Q, Frank M, Uitto J, Zhou LH. Extending the phenotypic spectrum of keratitis-ichthyosis-deafness syndrome: report of a patient with GJB2 (G12R) Connexin 26 mutation and unusual clinical findings. Pediatric dermatology; 29(3).
Lazic T, Fonder M, Robinson-Bostom L, Wilkel CS, Della Torre L. Orlistat-induced bullous leukocytoclastic vasculitis. Cutis 2013 Mar; 91(3).
Lazic T, Cantisani C. Male tuberculous mastitis: a rare entity. Clinical Therapy 2013;: 164 (4).
Bordelon J, Tang N, Elston D, Neidt G, Lazic-Strugar T. Multiple apocrine hidrocystomas successfully treated with Botulinum Toxin A. British Journal of Dermatology;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Lazic Strugar during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- La Roche-Posay
Scientific Advisory Board:
- Valeant Pharmaceuticals International, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.